About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.